CompaniesBioprocessing Inc.

Bioprocessing Inc.

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (5)
View all

Total Trials

5

As Lead Sponsor

3

As Collaborator

2

Total Enrollment

512

By Phase

PHASE2: 2PHASE1: 1PHASE3: 1NA: 1

By Status

COMPLETED: 4RECRUITING: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
NCT02187003
NCT04804241
Hover over trial bars to see details

Recent Trials

NCT05932654Lead Sponsor
POC Study to Evaluate BSI-045B in Moderate-to-severe Atopic Dermatitis
PHASE2Completed
22 participants
Started: Jul 31, 2023 · Completed: Sep 18, 2024
NCT04804241Collaborator
Senicapoc in Alzheimer's Disease
PHASE2Recruiting
55 participants
Started: Mar 18, 2022 · Completed: Jun 30, 2026
NCT05114889Lead Sponsor
Safety and Tolerability of BSI-045B in Healthy Adult Subjects and Patients With Atopic Dermatitis
PHASE1Completed
54 participants
Started: Oct 25, 2021 · Completed: Feb 15, 2023
NCT02187003Lead Sponsor
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
PHASE3Completed
345 participants
Started: Jun 17, 2015 · Completed: Jun 27, 2019
NCT01690312Collaborator
Clinical Study to Assess High-DHA Fish Oil on Biomarkers of Cardiovascular Disease Risk in Adults on Statin Therapy
NACompleted
36 participants
Started: Sep 30, 2012 · Completed: Feb 28, 2014